Impact of switching from neutral protamine hagedorn insulin (NPH) to glargine insulin on glycemic control and clinical outcomes in pediatric patients with type 1 diabetes
Switching from NPH to glargine insulin among Sudanese pediatric patients with type 1 diabetes offer significant benefits in glycemic control, as reflected by improved HbA1c and FBG levels. Additionally, insulin dose and weight increased, contributing to enhanced overall health and blood glucose management. Hypoglycemia was a major reason for switching.
Authors
- Omar Khalid
- Mohamed Esmail Karar (ORCID: https://orcid.org/0000-0002-0474-4723)
- H.A. Elsheikh (ORCID: https://orcid.org/0000-0002-7968-6572)
- Safaa Badi (ORCID: https://orcid.org/0000-0003-3204-983X)
- Mohamed Fouad (ORCID: https://orcid.org/0000-0001-6291-6784)
- A Kamal
- Omnia Abdullah
- Setana Mamoun
Institutions
- AlMughtaribeen University (SD)
- Omdurman Islamic University (SD)
- National University (SD)
Publication Details
- Journal
- Exploratory Research in Clinical and Social Pharmacy
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1016/j.rcsop.2025.100612
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universitas Nasional